Literature DB >> 12790159

Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study.

Luis G Almeida Montes1, Marta P Ontiveros Uribe, José Cortés Sotres, Gerardo Heinze Martin.   

Abstract

OBJECTIVE: To assess the hypnotic effect of melatonin in patients with primary insomnia.
METHOD: Ten patients (mean age 50 yr, range 30-72 yr) who met the DSM-IV criteria for primary insomnia received, in random order, 0.3 mg of melatonin, 1.0 mg of melatonin or placebo 60 minutes before bedtime. A crossover design was used so that each patient received each of the 3 treatments for a 7-day period (with a 5-day washout period between). After each 7-day treatment, night time electroencephalographic (EEG) records were collected, and each morning, subjects completed sleep logs and analogue-visual scales to document the amount and subjective quality of sleep.
RESULTS: There were no significant differences in sleep EEG, the amount or subjective quality of sleep or side effects between the placebo, 0.3-mg melatonin or 1.0-mg melatonin treatments.
CONCLUSION: Melatonin did not produce any sleep benefit in this sample of patients with primary insomnia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790159      PMCID: PMC161743     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  24 in total

1.  Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.

Authors:  D Dawson; N L Rogers; C J van den Heuvel; D J Kennaway; K Lushington
Journal:  J Biol Rhythms       Date:  1998-12       Impact factor: 3.182

Review 2.  Evaluation of chronic insomnia. An American Academy of Sleep Medicine review.

Authors:  M J Sateia; K Doghramji; P J Hauri; C M Morin
Journal:  Sleep       Date:  2000-03-15       Impact factor: 5.849

3.  Delayed sleep phase syndrome response to melatonin.

Authors:  M Dahlitz; B Alvarez; J Vignau; J English; J Arendt; J D Parkes
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

4.  EEG sleep evaluation of depression in borderline patients.

Authors:  E McNamara; C F Reynolds; P H Soloff; R Mathias; A Rossi; D Spiker; P A Coble; D J Kupfer
Journal:  Am J Psychiatry       Date:  1984-02       Impact factor: 18.112

5.  Free-running activity rhythms in the rat: entrainment by melatonin.

Authors:  J Redman; S Armstrong; K T Ng
Journal:  Science       Date:  1983-03-04       Impact factor: 47.728

Review 6.  The pineal gland: a neurochemical transducer.

Authors:  J Axelrod
Journal:  Science       Date:  1974-06-28       Impact factor: 47.728

7.  REM latency and the recovery from depression: getting over divorce.

Authors:  R D Cartwright; H M Kravitz; C I Eastman; E Wood
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

8.  Melatonin administration to blind people: phase advances and entrainment.

Authors:  R L Sack; A J Lewy; M L Blood; J Stevenson; L D Keith
Journal:  J Biol Rhythms       Date:  1991       Impact factor: 3.182

9.  The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: a preliminary study.

Authors:  J G MacFarlane; J M Cleghorn; G M Brown; D L Streiner
Journal:  Biol Psychiatry       Date:  1991-08-15       Impact factor: 13.382

10.  Melatonin administration in insomnia.

Authors:  S P James; D A Sack; N E Rosenthal; W B Mendelson
Journal:  Neuropsychopharmacology       Date:  1990-02       Impact factor: 7.853

View more
  9 in total

1.  Pharmacological Treatment of Insomnia.

Authors:  Janette D Lie; Kristie N Tu; Diana D Shen; Bonnie M Wong
Journal:  P T       Date:  2015-11

Review 2.  Do herbal agents have a place in the treatment of sleep problems in long-term care?

Authors:  Mark Shimazaki; Jennifer L Martin
Journal:  J Am Med Dir Assoc       Date:  2007-04-18       Impact factor: 4.669

3.  Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety.

Authors:  Larry Culpepper; Mark A Wingertzahn
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-31

4.  The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.

Authors:  Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Glen Baker; Terry P Klassen; Sunita Vohra
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

5.  Meta-analysis: melatonin for the treatment of primary sleep disorders.

Authors:  Eduardo Ferracioli-Oda; Ahmad Qawasmi; Michael H Bloch
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

Review 6.  The effectiveness of melatonin for promoting healthy sleep: a rapid evidence assessment of the literature.

Authors:  Rebecca B Costello; Cynthia V Lentino; Courtney C Boyd; Meghan L O'Connell; Cindy C Crawford; Meredith L Sprengel; Patricia A Deuster
Journal:  Nutr J       Date:  2014-11-07       Impact factor: 3.271

7.  The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study.

Authors:  Madhuri S Kurdi; Sindhu Priya Muthukalai
Journal:  Indian J Palliat Care       Date:  2016 Jul-Sep

Review 8.  Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Srujitha Marupuru; Daniel Arku; Ashley M Campbell; Marion K Slack; Jeannie K Lee
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

9.  Efficacy and hypnotic effects of melatonin in shift-work nurses: double-blind, placebo-controlled crossover trial.

Authors:  Khosro Sadeghniiat-Haghighi; Omid Aminian; Gholamreza Pouryaghoub; Zohreh Yazdi
Journal:  J Circadian Rhythms       Date:  2008-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.